Literature DB >> 27656075

Hip structure analysis by DXA of teriparatide treatment: A 24-month follow-up clinical study.

Takeshi Mochizuki1, Koichiro Yano2, Katsunori Ikari2, Kosei Kawakami1, Ryo Hiroshima1, Naoko Koenuma1, Mina Ishibashi1, Toshikatsu Shirahata3.   

Abstract

OBJECTIVE: The objective of this study was to perform a hip structure analysis (HSA) of teriparatide (TPTD) treatment in women with postmenopausal osteoporosis.
METHODS: The study included 96 patients with postmenopausal osteoporosis and received 20 μg TPTD daily. HSA was performed by dual-energy X-ray absorptiometry.
RESULTS: The percent changes from baseline for the cross-sectional moment of inertia, section modulus, buckling ratio, and femoral strength index based on HSA results were 9.8% (p < 0.01), 10.7%, 3.3%, and 14.9% (p < 0.01), respectively, at 24 months.
CONCLUSION: Based on the HSA results obtained with DXA, TPTD was effective for hip structures.

Entities:  

Keywords:  Dual-energy X-ray absorptiometry; Hip structure analysis; Osteoporosis; Rheumatoid arthritis; Teriparatide

Year:  2016        PMID: 27656075      PMCID: PMC5021820          DOI: 10.1016/j.jor.2016.09.001

Source DB:  PubMed          Journal:  J Orthop        ISSN: 0972-978X


  23 in total

1.  The effects of programmed administration of human parathyroid hormone fragment (1-34) on bone histomorphometry and serum chemistry in rats.

Authors:  H Dobnig; R T Turner
Journal:  Endocrinology       Date:  1997-11       Impact factor: 4.736

Review 2.  Assessment of fracture risk.

Authors:  John A Kanis; Frederik Borgstrom; Chris De Laet; Helena Johansson; Olof Johnell; Bengt Jonsson; Anders Oden; Niklas Zethraeus; Bruce Pfleger; Nikolai Khaltaev
Journal:  Osteoporos Int       Date:  2004-12-23       Impact factor: 4.507

3.  Geometric structure of the femoral neck measured using dual-energy x-ray absorptiometry.

Authors:  T Yoshikawa; C H Turner; M Peacock; C W Slemenda; C M Weaver; D Teegarden; P Markwardt; D B Burr
Journal:  J Bone Miner Res       Date:  1994-07       Impact factor: 6.741

4.  Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Vertebral Efficacy With Risedronate Therapy (VERT) Study Group.

Authors:  S T Harris; N B Watts; H K Genant; C D McKeever; T Hangartner; M Keller; C H Chesnut; J Brown; E F Eriksen; M S Hoseyni; D W Axelrod; P D Miller
Journal:  JAMA       Date:  1999-10-13       Impact factor: 56.272

5.  Risk of mortality following clinical fractures.

Authors:  J A Cauley; D E Thompson; K C Ensrud; J C Scott; D Black
Journal:  Osteoporos Int       Date:  2000       Impact factor: 4.507

6.  Effects of teriparatide [rhPTH (1-34)] treatment on structural geometry of the proximal femur in elderly osteoporotic women.

Authors:  Kirsti Uusi-Rasi; Lisa M Semanick; Jose R Zanchetta; Cesar E Bogado; Erik F Eriksen; Masahiko Sato; Thomas J Beck
Journal:  Bone       Date:  2005-06       Impact factor: 4.398

7.  A comparison of incidences of vertebral fracture in Japanese patients with involutional osteoporosis treated with risedronate and etidronate: a randomized, double-masked trial.

Authors:  Kazuhiro Kushida; Masao Fukunaga; Hideaki Kishimoto; Masataka Shiraki; Akira Itabashi; Tetsuro Inoue; Kiyoshi Kaneda; Hirotoshi Morii; Hajime Nawata; Kichizo Yamamoto; Yasuo Ohashi; Hajime Orimo
Journal:  J Bone Miner Metab       Date:  2004       Impact factor: 2.626

8.  Differing effects of PTH 1-34, PTH 1-84, and zoledronic acid on bone microarchitecture and estimated strength in postmenopausal women with osteoporosis: an 18-month open-labeled observational study using HR-pQCT.

Authors:  Stinus Hansen; Ellen M Hauge; Jens-Erik Beck Jensen; Kim Brixen
Journal:  J Bone Miner Res       Date:  2013-04       Impact factor: 6.741

9.  Anabolic effect of human parathyroid hormone fragment on trabecular bone in involutional osteoporosis: a multicentre trial.

Authors:  J Reeve; P J Meunier; J A Parsons; M Bernat; O L Bijvoet; P Courpron; C Edouard; L Klenerman; R M Neer; J C Renier; D Slovik; F J Vismans; J T Potts
Journal:  Br Med J       Date:  1980-06-07

Review 10.  The molecular mechanism of osteoclastogenesis in rheumatoid arthritis.

Authors:  Nobuyuki Udagawa; Shigeru Kotake; Naoyuki Kamatani; Naoyuki Takahashi; Tatsuo Suda
Journal:  Arthritis Res       Date:  2002-04-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.